GreyRigge Associates (GRA) is a biotech consultancy that works internationally helping both small and large biopharmaceutical companies in the development of medicines. GRA offers both technical and commercial support for biotech products including vaccines, gene & cell therapies, recombinant proteins and monoclonal antibodies, including biosimilars. GRA offers both consultancy and training services to clients covering CMC, including process, manufacturing & analytical development, Quality by Design (QbD), product formulation and stability, along with pre/non-clinical & toxicology support, quality management and regulatory support. GRA supports products across all phases of development, from preclinical, clinical phases I, II & III through to product launch.